GlassScriptPhysician profile
Erin K Newman
NPI 1396919866
$7,337.15
in general payments reported to CMS, 2019-2025
35 companies · $3,158 in 2025
The $3,158 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $357 · 2021: $201 · 2022: $363 · 2023: $246 · 2024: $2,575 · 2025: $3,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,200 · Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,200.00 |
| Food and Beverage | $778.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $5,200.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $428.14 | 2019-2025 | |
| Pfizer INC. | $318.75 | 2019-2025 | |
| Exeltis, USA INC. | $190.66 | 2019-2025 | Slynd |
| Merck Sharp & Dohme LLC | $112.51 | 2019-2022 | |
| Aspira Women'S Health INC | $110.08 | 2022 | |
| Sumitomo Pharma America, INC. | $103.66 | 2024-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $78.61 | 2023-2025 | Veozah |
| Meditrina | $76.55 | 2022-2025 | |
| Millicent US INC | $70.48 | 2020-2024 | Intrarosa |
| Amag Pharmaceuticals, INC. | $69.68 | 2019-2020 | |
| Organon LLC | $64.49 | 2021-2025 | Nexplanon |
| Mission Pharmacal Company | $46.45 | 2019-2020 | |
| Allergan, INC. | $40.60 | 2019 | |
| Therapeuticsmd, INC. | $38.35 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $36.66 | 2019-2020 | |
| Avion Pharmaceuticals | $26.99 | 2019-2020 | |
| Duchesnay USA Incorporated | $25.80 | 2019 | |
| Channel Medsystems, INC. | $24.83 | 2022 | |
| Shield Therapeutics INC | $24.76 | 2025 | |
| Vertical Pharmaceuticals, LLC | $24.20 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.53 | 2022 | |
| Coopersurgical, INC. | $20.90 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $19.24 | 2019 | |
| Hologic Sales and Service, LLC | $18.95 | 2025 | Myosure Tissue Removal Device, Novasure |
| Daiichi Sankyo INC. | $18.40 | 2020 | |
| Supernus Pharmaceuticals, INC. | $16.88 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $16.88 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $15.97 | 2019 | |
| Hologic INC | $15.82 | 2021 | |
| Amgen INC. | $14.63 | 2019 | |
| Minerva Surgical, INC | $13.87 | 2021 | |
| Kci USA, INC. | $12.41 | 2019 | |
| Dysis Medical, INC. | $11.55 | 2020 | |
| Bolder Surgical LLC | $7.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.